Belite Bio Inc's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Belite Bio Inc's ROA in the fourth quarter of 2025?
Belite Bio Inc recorded a cumulative net loss of $-78 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -9.94%.

However, within the Healthcare sector 343 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 3743.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Total Assets Change	381.82 %	428.65 %	428.65 %	428.65 %	57.25 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-78	-36	-36	-36	-36
Return On Assets (TTM)	-9.94 %	-5.77 %	-7.73 %	-11.68 %	-23.9 %
BLTE's Total Ranking	# 3743	#	#	#	# 4307
Total Assets (TTM) in million	781	781	781	781	162
Seq. Total Assets Change	0 %	0 %	0 %	381.82 %	9.72 %
Seq. Net Income Change	-	-	-	-	-

BLTE's 5 Years Annual ROA >> Back to BLTE Management Effectiveness >> Compare BLTE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 123
Sector	# 344
Overall	# 3711

Return On Assets Statistics
High	Average	Low
-9.94 %	-22.37 %	-33.42 %
(Dec 31 2025)		(Dec 31 2023)

Financial Statements
Belite Bio Inc's Assets	$ 781 million	BLTE's Balance sheet
Belite Bio Inc's Income	$ -78 million	Quarterly BLTE's Income Statement
BLTE's Income by Division		See BLTE's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	FY
Y / Y Total Assets Change	397.19 %	57.25 %	128.5 %	-	-
Total Assets in million	805	162	103	45	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-78	-36	-32	-13	0
Annual Return On Assets	-9.64 %	-22.31 %	-30.7 %	-28.05 %	-

BLTE's 5 Years Annual ROA >> Back to BLTE Management Effectiveness >> Compare BLTE ROA to its Competitors

More Return On Assets Ratios
BLTE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BLTE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BLTE's Competitors
Subscribers only: Roa for Belite Bio Inc's Suppliers
Subscribers only: Return On Assets for BLTE's Customers

You may also want to know
BLTE's Roi	BLTE's Inventory Turnover Ratio	BLTE's Growth Rates	BLTE's Dividend Comparisons
	BLTE's Profitability Ratios	BLTE's Asset Turnover Ratio	BLTE's Dividend Growth
BLTE's Roe	BLTE's Valuation Ratios	BLTE's Financial Strength Ratios	BLTE's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-07-07T09:35:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.